MetaCap

Virax Biolabs Group Statistics

NASDAQ: VRAXHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

0.3319-0.0491 (-12.89%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Virax Biolabs Group by the numbers

Virax Biolabs Group has a market capitalization of $446,401 based on 1.34M shares outstanding. With trailing EPS of $-12.64, Virax Biolabs Group is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 78.8% below its 50-day average and 90.4% below its 200-day average.

Average daily trading volume is 360.62K shares, or about $119,689 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

VRAX valuation vs. peer median

VRAX compared with the median of 8 peer companies
MetricVRAXPeer medianDifference
Market cap$446.40K$5.46M-92%
Avg. volume360.62K100.65K+258%

Peer median across 8 companies: QCLS, CDIO, BMRA, TRIB, VNRX, IMDX, ICCC, NNNN.

Valuation

Market cap
$446.40K
Price / sales (latest FY)
70.51
EPS (TTM)
$-12.64

Price and trading

Previous close
0.381
Open
0.3696
Day range
0.3287 – 0.3696
52-week range
0.293 – 21.75
Beta
—
Volume
85.67K

Dividends and events

Additional statistics

Market Cap
446.40K
Forward Pe
-0.06
Eps
-12.64
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
21.75
Week52 Low
0.29
Avg Volume
360.62K
Shares Outstanding
1.34M
Ma50
1.56
Ma200
3.45
Pct From52w High
-98.47%
Pct From52w Low
13.28%

Related